Compare this test’s laboratory options
Candida Antibody IgM
Access Labcorp Draw1 test optionFrom $122.49
Candida Antibody IgM
Access Labcorp DrawWhat this laboratory test evaluates
DetailsThis test measures IgM antibodies to Candida albicans. Candida-specific antibodies can be significantly elevated in systemic candidiasis. These antibodies have been identified in healthy individuals while poor antibody response is observed in immunocompromised patients.
What type of sample is required for this test?Serum
Additional test information
This test measures IgM antibodies to Candida albicans. Candida-specific antibodies can be significantly elevated in systemic candidiasis. These antibodies have been identified in healthy individuals while poor antibody response is observed in immunocompromised patients.
Collection and processing
- Sample type: Serum
- Fasting: No
- Estimated laboratory processing: Results should be available 1-5 business days after the lab receives samples.
How Sunridge uses laboratory information
Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.
Before requesting this test
Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.
About this test
DetailsThis test measures IgM antibodies to Candida albicans. Candida-specific antibodies can be significantly elevated in systemic candidiasis. These antibodies have been identified in healthy individuals while poor antibody response is observed in immunocompromised patients.
What type of sample is required for this test?Serum
Additional details
This test measures IgM antibodies to Candida albicans. Candida-specific antibodies can be significantly elevated in systemic candidiasis. These antibodies have been identified in healthy individuals while poor antibody response is observed in immunocompromised patients.
Highlighted health areas
- Infectious Disease
- Gastrointestinal
Biomarkers and report focus
The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.
- Candida IgM